SGP (SpyGlass Pharma) Insider Ownership: 3.54 % (As of Aug. 11, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SGP SpyGlass Pharma Inc SGP
12 GF Score
Price $25.07
View Full Analysis

What is SpyGlass Pharma Insider Ownership?

SpyGlass Pharma SGP -0.59% 12 Insider Ownership is 3.54 % as of Aug. 11, 2026. GuruFocus rates SGP with a GF Score™ of 12/100.

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, SpyGlass Pharma's insider ownership is 3.54%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, SpyGlass Pharma's Institutional Ownership is 76.78%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, SpyGlass Pharma's Float Percentage Of Total Shares Outstanding is 33.17%.

SpyGlass Pharma Insider Ownership Historical Data

* Premium members only.

The historical data trend for SpyGlass Pharma's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SpyGlass Pharma Insider Ownership Chart

SpyGlass Pharma Historical Data

The historical data trend for SpyGlass Pharma can be seen below:

2026-02-28 2026-05-31 2026-06-30 2026-07-31
Insider Ownership 3.54 3.54 3.54 3.54
SGP
12GF Score
SpyGlass Pharma Inc SGP
Insider Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

SpyGlass Pharma Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.

Frequently Asked Questions Learn more about Insider Ownership →
What does a Insider Ownership of 3.54 % mean?
SpyGlass Pharma (SGP) has a Insider Ownership of 3.54 % as of Aug. 11, 2026. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on SpyGlass Pharma and its competitors.
Is SpyGlass Pharma's Insider Ownership too high?
SpyGlass Pharma's current Insider Ownership is 3.54 %. Overall, SpyGlass Pharma has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does SpyGlass Pharma's Insider Ownership compare to RIGL and NGNE?
SpyGlass Pharma's Insider Ownership of 3.54 % can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Insider Ownership for a Biotechnology company?
A good Insider Ownership depends on the Biotechnology industry context. However, Insider Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Insider Ownership mean?
A high Insider Ownership can signal that a stock is expensive relative to its fundamentals. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on SpyGlass Pharma and its competitors. SpyGlass Pharma's current Insider Ownership is 3.54 %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SpyGlass Pharma stock overvalued right now?
SpyGlass Pharma (SGP) has a current Insider Ownership of 3.54 %. The current Insider Ownership is 3.54 %. SpyGlass Pharma's overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Insider Ownership calculated?
Insider Ownership is calculated from a company's financial statements. For SpyGlass Pharma (SGP), the current Insider Ownership is 3.54 % as of Aug. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

SpyGlass Pharma Business Description

Address 27061 Aliso Creek Road, Suite 100, Aliso Viejo, CA, USA, 92656
SpyGlass Pharma Inc is a late-stage biopharmaceutical company focused on transforming the treatment paradigm for patients living with chronic eye conditions through long-acting, sustained drug delivery of approved medicines. The company is developing two programs: the BIM-IOL System, which is intended for use during cataract surgery to deliver glaucoma treatment, and the BIM-DRS, which is designed for glaucoma patients who are not undergoing cataract surgery.
12GF Score

Get the complete analysis for SGP

Insider Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$25.07
Price